Amgen Inc (AMGN) Event May 18, 2022, 20:23 UTC (99% Neutral) AMGEN INC (AMGN) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 1, 2025, 9:15 p.m. 📋 AMGEN INC (AMGN) - Regulatory Update Filing Date: 2022-05-18 Accepted: 2022-05-18 16:23:12 Event Type: Regulatory Update Event Details: Amgen Inc (AMGN) Announces Regulatory Update Amgen Inc (AMGN) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 🔬 Clinical Development Pipeline (AMGEN INC): Product Type Development Stage Therapeutic Area Source Blinatumomab DRUG Phase PHASE2 Phase 2 Study ClinicalTrials.gov Placebo DRUG Phase PHASE3 Heart Failure With Preserved Ejection Fraction ClinicalTrials.gov Maridebart cafraglutide DRUG Phase PHASE3 Heart Failure With Preserved Ejection Fraction ClinicalTrials.gov Efavaleukin alfa DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov AMG 404 DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov Tarlatamab DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov Pembrolizumab (EU) DRUG Phase PHASE3 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer ClinicalTrials.gov Pembrolizumab (US) DRUG Phase PHASE3 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer ClinicalTrials.gov ABP 234 DRUG Phase PHASE3 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer ClinicalTrials.gov Abiraterone DRUG Phase PHASE1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) ClinicalTrials.gov Darolutamide DRUG Phase PHASE1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) ClinicalTrials.gov Xaluritamig DRUG Phase PHASE1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) ClinicalTrials.gov Etoposide DRUG Phase PHASE3 Small-cell Lung Cancer ClinicalTrials.gov Carboplatin DRUG Phase PHASE3 Small-cell Lung Cancer ClinicalTrials.gov Durvalumab DRUG Phase PHASE3 Small-cell Lung Cancer ClinicalTrials.gov Apremilast DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov Rocatinlimab DRUG Phase PHASE3 Prurigo Nodularis ClinicalTrials.gov Peer Support Program BEHAVIORAL Approved Rheumatoid Arthritis ClinicalTrials.gov Pembrolizumab DRUG Phase PHASE3 Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) ClinicalTrials.gov Teprotumumab BIOLOGICAL Phase PHASE3 Thyroid Eye Disease ClinicalTrials.gov Bevacizumab-awwb DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov Panitumumab DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov Sotorasib DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov FOLFIRI Regimen DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov Cabazitaxel DRUG Phase PHASE3 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov Enzalutamide DRUG Phase PHASE3 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov Olpasiran DRUG Phase PHASE3 Cardiovascular Disease ClinicalTrials.gov Etelcalcetide DRUG Phase PHASE3 Secondary Hyperparathyroidism ClinicalTrials.gov Pemetrexed DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov Paclitaxel DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov AMG 193 DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov Dazodalibep DRUG Phase PHASE3 Sjögren's Syndrome ClinicalTrials.gov ABP 692 DRUG Phase PHASE3 Relapsing-remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov Ocrelizumab (EU) DRUG Phase PHASE3 Relapsing-remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov Ocrelizumab (US) DRUG Phase PHASE3 Relapsing-remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov HZN-1116 DRUG Phase PHASE2 Sjogren's Syndrome ClinicalTrials.gov Alendronate DRUG Phase PHASE2 Osteoporosis ClinicalTrials.gov Romosozumab DRUG Phase PHASE2 Osteoporosis ClinicalTrials.gov Inebilizumab DRUG Phase PHASE2 Systemic Lupus Erythematosus ClinicalTrials.gov Talimogene laherparepvec BIOLOGICAL Phase PHASE1 Breast Cancer ClinicalTrials.gov Avacopan DRUG Phase PHASE2 Granulomatosis With Polyangiitis ClinicalTrials.gov Standard of Care DRUG Phase PHASE4 Antineutrophil Cytoplasmic Antibody-associated Vasculitis ClinicalTrials.gov Erenumab 140 mg DRUG Phase PHASE4 Migraine Headache ClinicalTrials.gov Erenumab 70 mg DRUG Phase PHASE4 Migraine Headache ClinicalTrials.gov AMG 420 DRUG Phase PHASE1 Relapsed and/or Refractory Multiple Myeloma ClinicalTrials.gov SOC chemotherapy regimen DRUG Phase PHASE3 Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov Low-intensity chemotherapy regimen DRUG Phase PHASE3 Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov olverembatinib DRUG Phase PHASE2 Phase II Clinical Trial ClinicalTrials.gov bemarituzumab, trifluridine/tipiracil DRUG Phase PHASE2 Metastatic Gastro-esophageal Adenocarcinoma ClinicalTrials.gov bemarituzumab, irinotecan DRUG Phase PHASE2 Metastatic Gastro-esophageal Adenocarcinoma ClinicalTrials.gov bemarituzumab, paclitaxel, ramucirumab DRUG Phase PHASE2 Metastatic Gastro-esophageal Adenocarcinoma ClinicalTrials.gov AMG 509 DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov Comparator AMG 193 Test Tablet DRUG Phase PHASE1 Advanced MTAP-null Solid Tumors ClinicalTrials.gov Docetaxel DRUG Phase PHASE1 Advanced MTAP-null Solid Tumors ClinicalTrials.gov Regorafenib DRUG Phase PHASE3 Colorectal Cancer (CRC) ClinicalTrials.gov Trifluridine and Tipiracil DRUG Phase PHASE3 Colorectal Cancer (CRC) ClinicalTrials.gov Romiplostim DRUG Phase PHASE3 Chemotherapy-induced Thrombocytopenia ClinicalTrials.gov Nivolumab DRUG Phase PHASE3 Melanoma ClinicalTrials.gov ABP 206 DRUG Phase PHASE3 Melanoma ClinicalTrials.gov Imlygic DRUG Phase PHASE1 NF1 ClinicalTrials.gov AMG 510 DRUG Phase PHASE3 KRAS p, G12c Mutated /Advanced Metastatic NSCLC ClinicalTrials.gov Denosumab DRUG Phase PHASE2 Smoldering Multiple Myeloma ClinicalTrials.gov Bisphosphonate DRUG Phase PHASE3 Osteogenesis Imperfecta ClinicalTrials.gov Atezolizumab DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov YL201 DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov MEDI9929 BIOLOGICAL Phase PHASE2 Atopic Dermatitis ClinicalTrials.gov Background Statin Therapy DRUG Phase PHASE3 Dyslipidemia ClinicalTrials.gov Evolocumab BIOLOGICAL Phase PHASE3 Dyslipidemia ClinicalTrials.gov Romiplostim (formerly AMG 531) DRUG Approved Hematology ClinicalTrials.gov CCX168 DRUG Phase PHASE2 Atypical Hemolytic Uremic Syndrome ClinicalTrials.gov Placebo SC DRUG Phase PHASE3 Fractures, Bone ClinicalTrials.gov Placebo IV DRUG Phase PHASE3 Fractures, Bone ClinicalTrials.gov Zoledronic acid 4 mg DRUG Phase PHASE3 Fractures, Bone ClinicalTrials.gov Denosumab 70 mg/mL BIOLOGICAL Phase PHASE3 Fractures, Bone ClinicalTrials.gov Autologous stem cell transplant PROCEDURE Phase PHASE2 Untreated CD20-positive Large B-cell Lymphoma ClinicalTrials.gov Rituximab + ACVBP regimen plus Pegfilgrastim DRUG Phase PHASE2 Untreated CD20-positive Large B-cell Lymphoma ClinicalTrials.gov Oprozomib DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov Placebo for denosumab DRUG Phase PHASE3 Steroid-induced Osteopor, Glucocorticoid-induced Ostepor ClinicalTrials.gov Risendronate DRUG Phase PHASE3 Steroid-induced Osteopor, Glucocorticoid-induced Ostepor ClinicalTrials.gov Placebo for risendronate DRUG Phase PHASE3 Steroid-induced Osteopor, Glucocorticoid-induced Ostepor ClinicalTrials.gov Personalized Patient Counselling BEHAVIORAL Phase PHASE4 Persistence to Enbrel ClinicalTrials.gov Cisplatin DRUG Phase PHASE2 Cancer ClinicalTrials.gov Dexamethasone DRUG Phase PHASE1 Lymphoma ClinicalTrials.gov Carfilzomib DRUG Phase PHASE1 Lymphoma ClinicalTrials.gov Bevacizumab DRUG Phase PHASE3 Non-small Cell Lung Cancer Metastatic ClinicalTrials.gov ABP 215 DRUG Phase PHASE3 Non-small Cell Lung Cancer Metastatic ClinicalTrials.gov saline placebo DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov G-CSF DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov vinorelbine DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov trastuzumab DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov Vitamin D DRUG Phase PHASE4 Chronic Kidney Disease ClinicalTrials.gov Cinacalcet DRUG Phase PHASE4 Chronic Kidney Disease ClinicalTrials.gov 5-Fluorouracil DRUG Phase PHASE2 Cancer ClinicalTrials.gov Irinotecan DRUG Phase PHASE2 Cancer ClinicalTrials.gov Leucovorin DRUG Phase PHASE2 Cancer ClinicalTrials.gov Placebo plus PLD DRUG Phase PHASE3 Fallopian Tube Cancer ClinicalTrials.gov AMG386 plus PLD DRUG Phase PHASE3 Fallopian Tube Cancer ClinicalTrials.gov panitumumab, mytomicin C, 5-FU, radiation DRUG Phase PHASE2 Anal Squamous Cell Carcinoma ClinicalTrials.gov Standard Chemotherapy DRUG Phase PHASE3 Cancer ClinicalTrials.gov Pegfilgrastim DRUG Phase PHASE3 Cancer ClinicalTrials.gov rituximab DRUG Phase PHASE3 Diffuse Large Cell Lymphoma ClinicalTrials.gov DMARD Therapy DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov etanercept DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov Any treatment for unresectable HCC as chosen by the physician DRUG Preclinical Carcinoma, Hepatocellular ClinicalTrials.gov Radiation Therapy RADIATION Phase PHASE2 Cancer of Head ClinicalTrials.gov Cytoxan DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov Doxorubicin DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov Temozolomide DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov Vincristine DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov AMG 386 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov AMG 386 + Paclitaxel DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Etanercept / Autoinjector A DRUG Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov Intensive Care OTHER Approved Psoriatic Arthritis (PsA) ClinicalTrials.gov RAD001 + AMG479 DRUG Phase PHASE1 Neoplasm Metastases ClinicalTrials.gov sorafenib tosylate DRUG Phase EARLY_PHASE1 Kidney Cancer ClinicalTrials.gov Etanercept via Autoinjector B DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov Etanercept via Autoinjector A DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov Placebo (for denosumab) DRUG Phase PHASE4 Hip Osteoarthritis ClinicalTrials.gov Denosumb DRUG Phase PHASE4 Hip Osteoarthritis ClinicalTrials.gov High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Methotrexate DRUG Phase PHASE4 Moderate to Severe Rheumatoid Arthritis ClinicalTrials.gov peripheral stem cell collection PROCEDURE Phase PHASE1 Diffuse Large B-cell Lymphoma (DLBCL) ClinicalTrials.gov Lenalidomide DRUG Phase PHASE1 Diffuse Large B-cell Lymphoma (DLBCL) ClinicalTrials.gov Cytarabine DRUG Phase PHASE1 Diffuse Large B-cell Lymphoma (DLBCL) ClinicalTrials.gov Everolimus DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov AMG 162 DRUG Phase PHASE3 Low Bone Mineral Density ClinicalTrials.gov Arm 2- Dose Expansion DRUG Phase PHASE1 Cancer ClinicalTrials.gov Arm 1- Dose Escalation DRUG Phase PHASE1 Cancer ClinicalTrials.gov Carfilzomib and Dexamethasone DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov Adalimumab BIOLOGICAL Phase PHASE3 Arthritis, Rheumatoid ClinicalTrials.gov ABP 501 BIOLOGICAL Phase PHASE3 Arthritis, Rheumatoid ClinicalTrials.gov AMG 102 and erlotinib DRUG Phase PHASE1 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov [¹⁴C]Etelcalcetide DRUG Phase PHASE1 Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis ClinicalTrials.gov Physician Survey OTHER Preclinical Solid Tumours ClinicalTrials.gov Traditional Vitamin D Therapy DRUG Phase PHASE4 Hyperparathyroidism, Secondary ClinicalTrials.gov AMG 167 DRUG Phase PHASE1 Osteopenia ClinicalTrials.gov Best Supportive Care (BSC) OTHER Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov Epirubicin, Cisplatin, Capecitabine DRUG Phase PHASE2 Stomach Neoplasms ClinicalTrials.gov Epirubicin, Cisplatin, Capecitabine, Panitumumab DRUG Phase PHASE2 Stomach Neoplasms ClinicalTrials.gov Group B: Carfilzomib & IMiD containing regimen. DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov Group A: Carfilzomib & Non-IMiD Regimen DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov Placebo to Atorvastatin DRUG Phase PHASE3 Primary Hyperlipidemia and Mixed Dyslipidemia ClinicalTrials.gov Placebo to Evolocumab DRUG Phase PHASE3 Primary Hyperlipidemia and Mixed Dyslipidemia ClinicalTrials.gov Atorvastatin DRUG Phase PHASE3 Primary Hyperlipidemia and Mixed Dyslipidemia ClinicalTrials.gov AMG 479 DRUG Phase PHASE2 Neuroendocrine Tumor ClinicalTrials.gov Palifermin DRUG Phase PHASE3 Head and Neck Cancer ClinicalTrials.gov Cyclophosphamide DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov AMG 282 Matching Placebo DRUG Phase PHASE1 Asthma ClinicalTrials.gov AMG 282 DRUG Phase PHASE1 Asthma ClinicalTrials.gov AMG 954/Panitumumab DRUG Phase PHASE1 Oncology ClinicalTrials.gov zoledronic acid DRUG Phase PHASE3 Bone Metastases ClinicalTrials.gov Standard Fractionation Radiotherapy RADIATION Phase PHASE2 Head and Neck Cancer ClinicalTrials.gov 60 mg denosumab DRUG Phase PHASE3 Low Bone Mass ClinicalTrials.gov Ferric carboxymaltose DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov Pertuzumab DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov Epirubicin DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov non-pegylated liposomal doxorubicin DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov Amgen 386 DRUG Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov AMG 337 DRUG Phase PHASE2 Stomach Neoplasms ClinicalTrials.gov Sorafenib (Nexavar, BAY43-9006) DRUG Phase PHASE3 Thyroid Neoplasms ClinicalTrials.gov 2=Clobetasol propionate foam DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov 1=Etanercept DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov AMG 108 BIOLOGICAL Phase PHASE2 Diabetes Mellitus ClinicalTrials.gov r-metHuLeptin DRUG Phase PHASE2 HAART-induced Lipodystrophy and Metabolic Syndrome ClinicalTrials.gov AMG 162 / Denosumab DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov AGT-182 DRUG Phase PHASE1 Mucopolysaccharidosis II ClinicalTrials.gov AMG 745 3.0 mg/kg DRUG Phase PHASE2 Age-associated Muscle Loss ClinicalTrials.gov AMG 745 1.0 mg/kg DRUG Phase PHASE2 Age-associated Muscle Loss ClinicalTrials.gov AMG 745 0.3 mg/kg DRUG Phase PHASE2 Age-associated Muscle Loss ClinicalTrials.gov Prednisone DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov Melphalan DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov AMG 319 DRUG Phase PHASE1 Cancer ClinicalTrials.gov Chemotherapy DRUG Phase PHASE2 Bone Pain in Stage I - III Breast Cancer ClinicalTrials.gov Loratadine DRUG Phase PHASE2 Bone Pain in Stage I - III Breast Cancer ClinicalTrials.gov Naproxen DRUG Phase PHASE2 Bone Pain in Stage I - III Breast Cancer ClinicalTrials.gov AGT-181 DRUG Phase PHASE1 Mucopolysaccharidosis I ClinicalTrials.gov Matching Placebo DRUG Phase PHASE1 Lupus Arthritis, Systemic Lupus Erythematosus ClinicalTrials.gov AMG 557 DRUG Phase PHASE1 Lupus Arthritis, Systemic Lupus Erythematosus ClinicalTrials.gov Quality Improvement Intervention BEHAVIORAL Approved Cardiovascular Diseases ClinicalTrials.gov AMG 706 DRUG Phase PHASE2 Advanced Non-squamous NSCLC ClinicalTrials.gov Cisplatin, 5-FU DRUG Phase PHASE3 Esophageal Squamous Cell Cancer ClinicalTrials.gov Decitabine DRUG Phase PHASE2 MDS ClinicalTrials.gov Azacitidine DRUG Phase PHASE2 MDS ClinicalTrials.gov AMG 531 (Romiplostim) BIOLOGICAL Phase PHASE2 MDS ClinicalTrials.gov Darbepoetin alfa DRUG Phase PHASE3 MDS ClinicalTrials.gov Best Supportive Care DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Intensity Modulated Radiation Therapy RADIATION Phase PHASE1 Squamous Cell Carcinoma of the Head and Neck ClinicalTrials.gov Midazolam DRUG Phase PHASE1 Postmenopausal Osteoporosis ClinicalTrials.gov Epoetin alfa DRUG Phase PHASE4 Renal Insufficiency, Chronic ClinicalTrials.gov Irinotecan Based Chemotherapy DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov Oxaliplatin Based Chemotherapy DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov Denosumab CP2 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov Denosumab CP4 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov Topical agents DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov AMG 386 Placebo DRUG Phase PHASE3 Fallopian Tube Cancer ClinicalTrials.gov Filgrastim DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov Herceptin DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov cyclophosphamide, methotrexate, fluorouracil, PEG-filgrastim DRUG Approved Breast Cancer ClinicalTrials.gov Sorafenib DRUG Phase PHASE1 Advanced Hepatocellular Carcinoma ClinicalTrials.gov teriparatide DRUG Phase PHASE2 Osteoporosis ClinicalTrials.gov Sunitinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov MEDI9929, 140 mg DRUG Phase PHASE1 Asthma ClinicalTrials.gov Panitumumab + FOLFOX (no-DP) DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov Panitumumab + FOLFOX (DP) DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov Erenumab DRUG Phase PHASE2 Stable Angina ClinicalTrials.gov Denosumab (CP4) DRUG Phase PHASE3 Postmenopausal Osteoporosis ClinicalTrials.gov Denosumab (CP2) DRUG Phase PHASE3 Postmenopausal Osteoporosis ClinicalTrials.gov Imaging OTHER Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov Panitumumab+FOLFIRI DRUG Phase PHASE2 Colorectal Cancer ClinicalTrials.gov Panitumumab+FOLFOX-4 DRUG Phase PHASE2 Colorectal Cancer ClinicalTrials.gov cyclosporine DRUG Phase PHASE2 AML ClinicalTrials.gov fludarabine DRUG Phase PHASE2 AML ClinicalTrials.gov No intervention OTHER Preclinical Non-Hodgkin's Lymphoma ClinicalTrials.gov AGT-181 (HIRMAb-IDUA) DRUG Phase PHASE1 Mucopolysaccharidosis I ClinicalTrials.gov VIB4920 DRUG Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov nbUVB phototherapy PROCEDURE Phase PHASE2 Vitiligo ClinicalTrials.gov AMG 714 BIOLOGICAL Phase PHASE2 Vitiligo ClinicalTrials.gov Omalizumab BIOLOGICAL Phase PHASE2 Chronic Spontaneous Urticaria ClinicalTrials.gov Tezepelumab Dose 2 BIOLOGICAL Phase PHASE2 Chronic Spontaneous Urticaria ClinicalTrials.gov Tezepelumab Dose 1 BIOLOGICAL Phase PHASE2 Chronic Spontaneous Urticaria ClinicalTrials.gov None, standard chemotherapy only OTHER Phase PHASE3 Lung Cancer Non-small Cell Stage IV ClinicalTrials.gov Famotidine DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov Omeprazole DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov Haplo-Mismatched Cell Therapy (HMCT) OTHER Phase PHASE1 B-Cell Acute Lymphoblastic Leukaemia ClinicalTrials.gov Consolidation with 4 cycles of CarCyDex DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Autologous Stem Cell Transplant (ASCT) PROCEDURE Phase PHASE2 Multiple Myeloma ClinicalTrials.gov AMG 340 DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov CCX354-C DRUG Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov CCX-354-C DRUG Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov CCX 354-C DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov Pegloticase BIOLOGICAL Phase PHASE4 Gout ClinicalTrials.gov Anti PD-1/L1 DRUG Phase PHASE1 KRAS p.G12C Mutant Advanced Solid Tumors ClinicalTrials.gov AMG 305 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov VIB1116 DRUG Phase PHASE1 Dendritic Cell -Mediated Rheumatic Diseases ClinicalTrials.gov Rocatinlimab vial injection DRUG Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov Moxifloxacin DRUG Phase PHASE1 Basic Science ClinicalTrials.gov Current Wearable Heatlth Monitoring System (CWHMS) DEVICE Phase PHASE4 B-precursor Acute Lymphoblastic Leukemia ClinicalTrials.gov self-directed Healing Circuits™ curriculum BEHAVIORAL Approved Crohn Disease (CD) ClinicalTrials.gov Healing Circuits™ sessions BEHAVIORAL Approved Crohn Disease (CD) ClinicalTrials.gov XGEVA® DRUG Phase PHASE4 Giant Cell Tumor of Bone ClinicalTrials.gov Itraconazole DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov placebo solution (10% dextrose) DRUG Phase PHASE2 Hepatic Encephalopathy ClinicalTrials.gov sodium phenylacetate and sodium benzoate injection 10% / 10% DRUG Phase PHASE2 Hepatic Encephalopathy ClinicalTrials.gov Ipilimumab DRUG Phase PHASE2 Colon Cancer ClinicalTrials.gov TAP® Micro Select Device (Touch Activated Phlebotomy) DEVICE Preclinical Obesity ClinicalTrials.gov Metformin DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov CCX282-B DRUG Phase PHASE2 Celiac Disease ClinicalTrials.gov CCX140-B DRUG Phase PHASE2 Diabetic Nephropathy ClinicalTrials.gov AMG 133 DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov Methotrexate (MTX) DRUG Phase PHASE4 Uncontrolled Gout ClinicalTrials.gov AMG 691 DRUG Phase PHASE1 Asthma ClinicalTrials.gov erenumab-aooe DRUG Preclinical Migraine ClinicalTrials.gov Placebo for Rozibafusp Alfa DRUG Phase PHASE2 Systemic Lupus Erythematosus (SLE) ClinicalTrials.gov Rozibafusp Alfa DRUG Phase PHASE2 Systemic Lupus Erythematosus (SLE) ClinicalTrials.gov Bemarituzumab DRUG Phase PHASE3 Gastric Cancer ClinicalTrials.gov MP-376 DRUG Phase PHASE2 Chronic Obstructive Pulmonary Disease ClinicalTrials.gov Early Intervention BEHAVIORAL Approved Cardiovascular Diseases ClinicalTrials.gov Ivabradine DRUG Phase PHASE4 Heart Failure ClinicalTrials.gov MTX/ARA-C DRUG Phase PHASE2 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov Mini-CVD DRUG Phase PHASE2 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov HZT-501 DRUG Phase PHASE3 Osteoarthritis ClinicalTrials.gov Talimogene Laherparepvec (T-VEC) DRUG Phase PHASE2 Sarcoma ClinicalTrials.gov Aflibercept DRUG Phase PHASE3 Chorioretinal Vascular Disease ClinicalTrials.gov ABP 938 DRUG Phase PHASE3 Chorioretinal Vascular Disease ClinicalTrials.gov AMG 410 DRUG Phase PHASE1 KRAS Altered Advanced or Metastatic Solid Tumors ClinicalTrials.gov AMG 794 DRUG Phase PHASE1 Non-squamous Non-small Cell Lung Cancer ClinicalTrials.gov RP103 DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov dasatinib DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov Drug: Carfilzomib + Lenalidomide + Dexamethasone DRUG Phase PHASE4 Relapsed Refractory Multiple Myeloma ClinicalTrials.gov Drug: Carfilzomib + Dexamethasone DRUG Phase PHASE4 Relapsed Refractory Multiple Myeloma ClinicalTrials.gov FOLFOX regimen DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov CRS Mitigation Strategies DRUG Phase PHASE1 Small Cell Lung Carcinoma ClinicalTrials.gov Gemcitabine DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Nab paclitaxel DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Tamoxifen DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Letrozole DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Fulvestrant DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Exemestane DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Anastrozole DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov Placebo Alendronate DRUG Phase PHASE2 Osteoporosis, Post-menopausal ClinicalTrials.gov Placebo Romosozumab DRUG Phase PHASE2 Osteoporosis, Post-menopausal ClinicalTrials.gov Alendronate (Fosamax) DRUG Phase PHASE2 Osteoporosis, Post-menopausal ClinicalTrials.gov Lp(a) Screening OTHER Approved Atherosclerotic Cardiovascular Disease ClinicalTrials.gov AMG 176 DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov Cystagon® DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov Care Champion Intervention OTHER Approved ASCVD ClinicalTrials.gov Warfarin DRUG Phase EARLY_PHASE1 Atopic Dermatitis ClinicalTrials.gov Metoprolol DRUG Phase EARLY_PHASE1 Atopic Dermatitis ClinicalTrials.gov MP-376 (Levofloxacin solution for Inhalation) DRUG Phase PHASE1 Cystic Fibrosis ClinicalTrials.gov Cysteamine Bitartrate Delayed-release Capsules DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov Hypofractionated Radiotherapy RADIATION Phase PHASE2 Melanoma ClinicalTrials.gov TALIMOGENE LAHERPAREPVEC (TVEC) DRUG Phase PHASE2 Melanoma ClinicalTrials.gov Daunorubicin DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov 6-Mercaptopurine DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate) DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov Intrathecal (IT) Methotrexate DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov PEG-asparaginase DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov Mitoxantrone DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov Prolia DRUG Phase PHASE4 Osteoporosis ClinicalTrials.gov Ibuprofen DRUG Phase PHASE3 Peptic Ulcer ClinicalTrials.gov UPLIZNA DRUG Preclinical Neuromyelitis Optica Spectrum Disorder ClinicalTrials.gov 800 mg ibuprofen/26.6 mg famotidine DRUG Phase PHASE4 Juvenile Idiopathic Arthritis ClinicalTrials.gov Injection of TVEC into target lesions 2wks after 3rd injection DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov Injection of TVEC into target lesions 2wks after 2nd injection DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov Injection of TVEC into target lesions 3wks after 1st injection DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov Injection of TVEC into target lesions - week 1-2 DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov Erenumab Prefilled Syringe DRUG Phase PHASE4 Facial Pain ClinicalTrials.gov Placebos DRUG Phase PHASE2 Acute Coronary Syndrome ClinicalTrials.gov T-VEC DRUG Phase PHASE2 Melanoma Stage III ClinicalTrials.gov Prolia® DRUG Phase PHASE4 Glucocorticoid-induced Osteoporosis ClinicalTrials.gov VIB9600 BIOLOGICAL Phase PHASE1 Safety Issues ClinicalTrials.gov interferon γ-1b DRUG Phase PHASE3 Friedreich's Ataxia ClinicalTrials.gov standard of care second-line chemotherapy (FOLFIRI) DRUG Phase PHASE2 Advanced Neuroendocrine Carcinomas of The Digestive System ClinicalTrials.gov RAYOS (delayed-release prednisone) DRUG Preclinical Rheumatoid Arthritis ClinicalTrials.gov Erenumab Dose 3 DRUG Phase PHASE3 Migraine ClinicalTrials.gov Erenumab Dose 2 DRUG Phase PHASE3 Migraine ClinicalTrials.gov Erenumab Dose 1 DRUG Phase PHASE3 Migraine ClinicalTrials.gov Observation OTHER Preclinical Multiple Myeloma ClinicalTrials.gov AMG 701 DRUG Preclinical None ClinicalTrials.gov Blood Red Cell Transfusion PROCEDURE Phase PHASE3 Myelodysplastic Syndrome ClinicalTrials.gov Darbepoetin alpha DRUG Phase PHASE3 Myelodysplastic Syndrome ClinicalTrials.gov AMG 786 DRUG Phase PHASE1 Obesity ClinicalTrials.gov Daxdilimab DRUG Phase PHASE2 Idiopathic Inflammatory Myositis ClinicalTrials.gov Amrubicin DRUG Phase PHASE3 Small Cell Lung Cancer (SCLC) ClinicalTrials.gov Topotecan DRUG Phase PHASE3 Small Cell Lung Cancer (SCLC) ClinicalTrials.gov Lurbinectedin DRUG Phase PHASE3 Small Cell Lung Cancer (SCLC) ClinicalTrials.gov IDE397 DRUG Phase PHASE1 MTAP-null Non-Small-Cell Lung Cancer ClinicalTrials.gov Cysteamine Bitartrate DRUG Phase PHASE2 Inherited Mitochondrial Disease, Including Leigh Syndrome ClinicalTrials.gov IV Placebo DRUG Phase PHASE3 Myasthenia Gravis ClinicalTrials.gov Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov Usual Care OTHER Approved Hip Fractures ClinicalTrials.gov Otago Exercise Program BEHAVIORAL Approved Hip Fractures ClinicalTrials.gov HZN-825 DRUG Phase PHASE2 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov AMG 994 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Sequential Radiation therapy RADIATION Phase PHASE1 Melanoma ClinicalTrials.gov Concurrent Radiation Therapy RADIATION Phase PHASE1 Melanoma ClinicalTrials.gov Denosumab Q4W DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Ethanol OTHER Phase PHASE2 Aldehyde Dehydrogenase-2 (ALDH2) Deficiency ClinicalTrials.gov Antizol DRUG Phase PHASE2 Aldehyde Dehydrogenase-2 (ALDH2) Deficiency ClinicalTrials.gov Cytochrome P450 (CYP) Cocktail DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov acapatamab DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov Denosumab 60 MG/ML Prefilled Syringe [Prolia] DRUG Phase PHASE2 Premenopausal Idiopathic Osteoporosis ClinicalTrials.gov Romosozumab Prefilled Syringe [Evenity] DRUG Phase PHASE2 Premenopausal Idiopathic Osteoporosis ClinicalTrials.gov AMG 171 DRUG Phase PHASE1 Obesity ClinicalTrials.gov AMG 596 DRUG Phase PHASE1 Glioblastoma or Malignant Glioma ClinicalTrials.gov leucovorin calcium DRUG Phase PHASE2 Mucinous Adenocarcinoma of the Colon ClinicalTrials.gov fluorouracil DRUG Phase PHASE2 Mucinous Adenocarcinoma of the Colon ClinicalTrials.gov irinotecan hydrochloride DRUG Phase PHASE2 Mucinous Adenocarcinoma of the Colon ClinicalTrials.gov Standard of care (SOC) DRUG Phase PHASE4 STEMI - ST Elevation Myocardial Infarction ClinicalTrials.gov Evolocumab 140 MG/ML DRUG Phase PHASE4 STEMI - ST Elevation Myocardial Infarction ClinicalTrials.gov AMG 732 DRUG Phase PHASE1 Thyroid Eye Disease ClinicalTrials.gov Ibuprofen/famotidine DRUG Phase PHASE3 Ulcer ClinicalTrials.gov Motesanib DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov Capecitabine DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov Ixabepilone DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov Tarlatamab treatment DRUG Phase PHASE2 DLL3-expressing Tumors ClinicalTrials.gov Alendronate Effervescent Oral Tablet DRUG Phase PHASE2 Erosive Osteoarthritis ClinicalTrials.gov SOX DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov CAPOX DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov Methylprednisolone DRUG Phase PHASE2 Allografts ClinicalTrials.gov Thymoglobulin DRUG Phase PHASE2 Allografts ClinicalTrials.gov Belatacept DRUG Phase PHASE2 Allografts ClinicalTrials.gov DMAB Discontinuation and Switching DRUG Phase PHASE4 Osteoporosis ClinicalTrials.gov Routine Lipid Management DRUG Phase PHASE4 Cardiovascular Disease ClinicalTrials.gov Laboratory Biomarker Analysis OTHER Phase PHASE2 Breast Carcinoma ClinicalTrials.gov Bloods and urine OTHER Preclinical Myeloma ClinicalTrials.gov DXA scan OTHER Preclinical Myeloma ClinicalTrials.gov Diffusion Weighted Magnetic Resonance Imaging (DWMRI) OTHER Preclinical Myeloma ClinicalTrials.gov Donor Leukocyte Infusion (DLI) BIOLOGICAL Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov Interferon gamma-1b DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov Ibrutinib DRUG Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov Carfilzomib + Ibrutinib DRUG Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov VIB7734 DRUG Phase PHASE1 Systemic Lupus Erythematosus ClinicalTrials.gov Radiotherapy RADIATION Phase PHASE1 Soft Tissue Sarcoma ClinicalTrials.gov Questionnaire OTHER Preclinical Psoriatic Arthritis ClinicalTrials.gov Nab-paclitaxel DRUG Phase PHASE1 Squamous-Cell Non-Small-Cell Lung Cancer ClinicalTrials.gov Pharmacological Study OTHER Phase PHASE1 CD20 Positive ClinicalTrials.gov Ifosfamide DRUG Phase PHASE1 CD20 Positive ClinicalTrials.gov Extended Consultation for apremilast BEHAVIORAL Phase EARLY_PHASE1 Psoriasis ClinicalTrials.gov Reminder Text Intervention with apremilast BEHAVIORAL Phase EARLY_PHASE1 Psoriasis ClinicalTrials.gov Otezla - Standard Care DRUG Phase EARLY_PHASE1 Psoriasis ClinicalTrials.gov AMG 427 DRUG Phase PHASE1 Relapsed/Refractory Acute Myeloid Leukemia (AML) ClinicalTrials.gov Pomalidomide DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Belantamab mafodotin DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov AMG 355 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov AMG 513 DRUG Phase PHASE1 Cardiometabolic Disease ClinicalTrials.gov Aeroquin DRUG Phase PHASE3 Cystic Fibrosis ClinicalTrials.gov Daratumumab DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Montelukast DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Diphenhydramine DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Acetaminophen DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Bortezomib DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov MR prednisone DRUG Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov TIS (Tobramycin Inhalation Solution) DRUG Phase PHASE3 Cystic Fibrosis ClinicalTrials.gov MEDI7734 BIOLOGICAL Phase PHASE1 Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc ClinicalTrials.gov Placebo, twice daily, plus cyclophosphamide/rituximab plus glucocorticoids OTHER Phase PHASE2 ANCA-associated Vasculitis ClinicalTrials.gov CCX168 30 mg, twice daily, cyclophosphamide/rituximab plus glucocorticoids DRUG Phase PHASE2 ANCA-associated Vasculitis ClinicalTrials.gov CCX168 10 mg, twice daily, plus cyclophosphamide/rituximab plus glucocorticoids DRUG Phase PHASE2 ANCA-associated Vasculitis ClinicalTrials.gov Isatuximab BIOLOGICAL Phase PHASE1 Multiple Myeloma ClinicalTrials.gov HZN-825 QD DRUG Phase PHASE2 Diffuse Cutaneous Systemic Sclerosis ClinicalTrials.gov HZN-825 BID DRUG Phase PHASE2 Diffuse Cutaneous Systemic Sclerosis ClinicalTrials.gov AMG 890 DRUG Phase PHASE1 Cardiovascular Disease ClinicalTrials.gov Ziftomenib DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov Mercaptopurine DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov Vorinostat DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov PEG asparaginase DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov normal saline DRUG Phase PHASE2 Thyroid Associated Ophthalmopathies ClinicalTrials.gov Alendronate 70Mg Tab DRUG Phase PHASE3 Bone Density, Low ClinicalTrials.gov Romosozumab Prefilled Syringe DRUG Phase PHASE3 Bone Density, Low ClinicalTrials.gov Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov BI 1701963 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov IV Chemotherapy (Regimen 2) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov IV Chemotherapy (Regimen 1) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov TNO155 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov MVASI® (bevacizumab-awwb) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Palbociclib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Carboplatin, pemetrexed, docetaxel, paclitaxel DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Afatinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov RMC-4630 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Trametinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Avacopan Matching Placebo DRUG Phase PHASE2 C3 Glomerulopathy (C3G) ClinicalTrials.gov Digoxin DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov AMG 199 DRUG Phase PHASE1 MUC17-positive Solid Tumors ClinicalTrials.gov Surgery PROCEDURE Phase PHASE2 Soft Tissue Sarcoma ClinicalTrials.gov Neoadjuvant Radiation RADIATION Phase PHASE2 Soft Tissue Sarcoma ClinicalTrials.gov Cortancyl DRUG Phase PHASE2 Asthma ClinicalTrials.gov Lodotra DRUG Phase PHASE2 Asthma ClinicalTrials.gov Blinatumomab 28 ug DRUG Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov Blinatumomab 9ug DRUG Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov mFOLFOX6 DRUG Phase PHASE3 Gastric Cancer ClinicalTrials.gov EU-authorized Nivolumab DRUG Phase PHASE3 Melanoma ClinicalTrials.gov FDA-licensed Nivolumab DRUG Phase PHASE3 Melanoma ClinicalTrials.gov VIMOVO 500/20 DRUG Phase PHASE4 Juvenile Idiopathic Arthritis (JIA) ClinicalTrials.gov VIMOVO 375/20 DRUG Phase PHASE4 Juvenile Idiopathic Arthritis (JIA) ClinicalTrials.gov VIMOVO 250/20 DRUG Phase PHASE4 Juvenile Idiopathic Arthritis (JIA) ClinicalTrials.gov Rifampin DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov AB248 DRUG Phase PHASE1 Extensive Stage Small Cell Lung Cancer ClinicalTrials.gov CCX872-B DRUG Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov AMG 119 BIOLOGICAL Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov Opportunistic screening for low BMD DEVICE Approved Low Bone Density ClinicalTrials.gov Placebo 1.7 ml Subcutaneous Solution DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA] DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov Blood tests OTHER Phase PHASE4 Neuromyelitis Optica Spectrum Disorder ClinicalTrials.gov RMC-6236 DRUG Phase PHASE1 Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers ClinicalTrials.gov Modified FOLFIRINOX DRUG Phase PHASE1 Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers ClinicalTrials.gov Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments DRUG Phase PHASE2 Temporomandibular Disorder ClinicalTrials.gov Erenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments DRUG Phase PHASE2 Temporomandibular Disorder ClinicalTrials.gov Placebo (Normal Saline) DRUG Phase PHASE2 Lupus Nephritis ClinicalTrials.gov pioglitazone DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov Ponatinib DRUG Phase PHASE2 Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive ClinicalTrials.gov Azathioprine DRUG Phase PHASE3 ANCA-Associated Vasculitis ClinicalTrials.gov Apremilast (CC-10004) Placebo OTHER Phase PHASE4 Arthritis, Psoriatic ClinicalTrials.gov Apremilast (CC-10004) DRUG Phase PHASE4 Arthritis, Psoriatic ClinicalTrials.gov Trebananib DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov Cetuximab DRUG Phase PHASE2 Cancer of the Colon ClinicalTrials.gov ASCT PROCEDURE Phase PHASE3 Multiple Myeloma ClinicalTrials.gov Ustekinumab DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov ABP 654 DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov AMG 256 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov Placebo to Alendronate DRUG Phase PHASE3 Postmenopausal Women With Osteoporosis ClinicalTrials.gov Placebo to Romosozumab DRUG Phase PHASE3 Postmenopausal Women With Osteoporosis ClinicalTrials.gov AMG 378 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov Gastro-Retentive (GR) Formulation DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov Immediate Release (IR) Formulation DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov Cysteamine Bitartrate Delayed-release Capsules (RP103) DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov Cystagon® (Cysteamine Bitartrate) DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov Pegloticase with MTX BIOLOGICAL Phase PHASE4 Chronic Uncontrolled Gout ClinicalTrials.gov Lenvatinib DRUG Phase PHASE2 Metastatic Non Small Cell Lung Cancer ClinicalTrials.gov 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Amgen IncCIK: 0000318154Ticker Symbol: AMGNPeriod End Date: 2022-05-17Document Type: 8-K
📋 AMGEN INC (AMGN) - Regulatory Update
Filing Date: 2022-05-18
Accepted: 2022-05-18 16:23:12
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (AMGEN INC):
💼 Business Developments:
Structured Data: